Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting

Sepideh Gholami; Mustafa Abidalhassan; May Cho; Anwaar Saeed; Flavio G. Rocha

doi:10.1007/s12029-022-00849-5

Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting

Sepideh Gholami, Mustafa Abidalhassan, May Cho, Anwaar Saeed, Flavio G. Rocha

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Purpose: To provide an overview of the key findings from studies in upper gastrointestinal, hepatobiliary, pancreas, and colorectal malignancies presented at ASCO GI 2022. Methods: We reviewed the abstracts presented at ASCO GI 2022. The studies highlighted were selected by the authors based on their significant discoveries and potential impact on clinical practice. Results and Conclusion: This year’s hybrid ASCO-GI symposium (2022) introduced many promising new treatment strategies in GI oncology, with several changes in clinical practice for patients with advanced hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic colorectal cancer (CRC).

Original language	English (US)
Pages (from-to)	672-676
Number of pages	5
Journal	Journal of Gastrointestinal Cancer
Volume	54
Issue number	2
DOIs	https://doi.org/10.1007/s12029-022-00849-5
State	Published - Jun 2023

Keywords

ASCO-GI symposium
Colorectal cancer
Esophygeal cancer
Gastric cancer
Hepatobiliary cancers
Pancreatic cancer

ASJC Scopus subject areas

Oncology
Gastroenterology

Access to Document

10.1007/s12029-022-00849-5

Cite this

@article{6c9529632d744e89b6c4590140e2ff0b,

title = "Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting",

abstract = "Purpose: To provide an overview of the key findings from studies in upper gastrointestinal, hepatobiliary, pancreas, and colorectal malignancies presented at ASCO GI 2022. Methods: We reviewed the abstracts presented at ASCO GI 2022. The studies highlighted were selected by the authors based on their significant discoveries and potential impact on clinical practice. Results and Conclusion: This year{\textquoteright}s hybrid ASCO-GI symposium (2022) introduced many promising new treatment strategies in GI oncology, with several changes in clinical practice for patients with advanced hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic colorectal cancer (CRC).",

keywords = "ASCO-GI symposium, Colorectal cancer, Esophygeal cancer, Gastric cancer, Hepatobiliary cancers, Pancreatic cancer",

author = "Sepideh Gholami and Mustafa Abidalhassan and May Cho and Anwaar Saeed and Rocha, {Flavio G.}",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2023",

month = jun,

doi = "10.1007/s12029-022-00849-5",

language = "English (US)",

volume = "54",

pages = "672--676",

journal = "Journal of Gastrointestinal Cancer",

issn = "1941-6628",

publisher = "Humana Press",

number = "2",

}

TY - JOUR

T1 - Current Progress and Advances in Gastrointestinal Cancers

T2 - Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting

AU - Gholami, Sepideh

AU - Abidalhassan, Mustafa

AU - Cho, May

AU - Saeed, Anwaar

AU - Rocha, Flavio G.

PY - 2023/6

Y1 - 2023/6

N2 - Purpose: To provide an overview of the key findings from studies in upper gastrointestinal, hepatobiliary, pancreas, and colorectal malignancies presented at ASCO GI 2022. Methods: We reviewed the abstracts presented at ASCO GI 2022. The studies highlighted were selected by the authors based on their significant discoveries and potential impact on clinical practice. Results and Conclusion: This year’s hybrid ASCO-GI symposium (2022) introduced many promising new treatment strategies in GI oncology, with several changes in clinical practice for patients with advanced hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic colorectal cancer (CRC).

AB - Purpose: To provide an overview of the key findings from studies in upper gastrointestinal, hepatobiliary, pancreas, and colorectal malignancies presented at ASCO GI 2022. Methods: We reviewed the abstracts presented at ASCO GI 2022. The studies highlighted were selected by the authors based on their significant discoveries and potential impact on clinical practice. Results and Conclusion: This year’s hybrid ASCO-GI symposium (2022) introduced many promising new treatment strategies in GI oncology, with several changes in clinical practice for patients with advanced hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic colorectal cancer (CRC).

KW - ASCO-GI symposium

KW - Colorectal cancer

KW - Esophygeal cancer

KW - Gastric cancer

KW - Hepatobiliary cancers

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=85134493435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85134493435&partnerID=8YFLogxK

U2 - 10.1007/s12029-022-00849-5

DO - 10.1007/s12029-022-00849-5

M3 - Article

C2 - 35856132

AN - SCOPUS:85134493435

SN - 1941-6628

VL - 54

SP - 672

EP - 676

JO - Journal of Gastrointestinal Cancer

JF - Journal of Gastrointestinal Cancer

IS - 2

ER -

Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this